olmesartan has been researched along with cefmetazole in 1 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (cefmetazole) | Trials (cefmetazole) | Recent Studies (post-2010) (cefmetazole) |
---|---|---|---|---|---|
841 | 185 | 554 | 406 | 60 | 61 |
Protein | Taxonomy | olmesartan (IC50) | cefmetazole (IC50) |
---|---|---|---|
Insulin-degrading enzyme | Homo sapiens (human) | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amano, N; Maeda, K; Moriwaki, T; Nakakariya, M; Ono, M; Sugiyama, Y | 1 |
1 other study(ies) available for olmesartan and cefmetazole
Article | Year |
---|---|
In vivo biliary clearance should be predicted by intrinsic biliary clearance in sandwich-cultured hepatocytes.
Topics: Angiotensin Receptor Antagonists; Animals; beta-Lactams; Biliary Tract; Biological Transport; Cells, Cultured; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pharmaceutical Preparations; Rats; Rats, Sprague-Dawley; Topotecan | 2012 |